On-X LTI Enters License and Development Agreement

On-X Life Technologies Enters License and Development Agreement with Cleveland Clinic Surgical System to Repair Mitral Valve Chordae System is intended to improve mitral valve repair and simplify procedure for cardiac surgeons AUSTIN, TX — December 8, 2009 — On-X® Life Technologies, Inc. (On-X LTI), manufacturers of the On-X® Prosthetic Heart Valve announced today that […]

On-X LTI Completes Enrollment

On-X Life Technologies Completes Enrollment in High-Risk Patient Group Low Anticoagulation Trial Data from the PROACT Trial may provide evidence that the On-X valve may be appropriately maintained at lower levels of anticoagulation AUSTIN, TX — October 20, 2009 — On-X® Life Technologies, Inc. (On-X LTI), manufacturers of the On-X® Prosthetic Heart Valve and On-X® […]

On-X Valve Reduced Anticoagulation Clinical Trial

FDA approved an investigational device exemption clinical trial of the On-X Prosthetic Heart Valve Successful completion of the clinical study could result in the On-X valve becoming the only mechanical heart valve approved for low-dose anticoagulation therapy. AUSTIN, TX — January 13, 2006 — The U.S. Food and Drug Administration (FDA) has approved an investigational […]

US Clinical Trials Expand

MCRI to expand the number of clinical centers for the On-X valve FDA study AUSTIN, TX — December 01, 1998 – The U.S. Food and Drug Administration granted unconditional Investigational Device Exemption (IDE) that allows MCRI to expand the number of clinical centers for the On-X valve FDA study in the United States. This IDE […]

Onxlti Responsive Menu
Menu